CA2116956C - Pharmaceutical process - Google Patents

Pharmaceutical process Download PDF

Info

Publication number
CA2116956C
CA2116956C CA002116956A CA2116956A CA2116956C CA 2116956 C CA2116956 C CA 2116956C CA 002116956 A CA002116956 A CA 002116956A CA 2116956 A CA2116956 A CA 2116956A CA 2116956 C CA2116956 C CA 2116956C
Authority
CA
Canada
Prior art keywords
weight
starch
propionic acid
isobutylphenyl
agglomerates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002116956A
Other languages
English (en)
French (fr)
Other versions
CA2116956A1 (en
Inventor
Graham J. Atkin
Peter Drew
John L. Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of CA2116956A1 publication Critical patent/CA2116956A1/en
Application granted granted Critical
Publication of CA2116956C publication Critical patent/CA2116956C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002116956A 1991-09-06 1992-08-25 Pharmaceutical process Expired - Fee Related CA2116956C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9119052.0 1991-09-06
GB919119052A GB9119052D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions
PCT/EP1992/001953 WO1993004676A1 (en) 1991-09-06 1992-08-25 High content ibuprofen agglomerates and process to prepare them

Publications (2)

Publication Number Publication Date
CA2116956A1 CA2116956A1 (en) 1993-03-18
CA2116956C true CA2116956C (en) 2002-07-16

Family

ID=10700981

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002116956A Expired - Fee Related CA2116956C (en) 1991-09-06 1992-08-25 Pharmaceutical process

Country Status (16)

Country Link
US (1) US5512302A (OSRAM)
EP (1) EP0602112B1 (OSRAM)
JP (1) JP3444597B2 (OSRAM)
KR (1) KR100253046B1 (OSRAM)
AT (1) ATE353213T1 (OSRAM)
AU (1) AU655673B2 (OSRAM)
CA (1) CA2116956C (OSRAM)
CZ (1) CZ282271B6 (OSRAM)
DE (1) DE69233678T2 (OSRAM)
FI (1) FI107878B (OSRAM)
GB (1) GB9119052D0 (OSRAM)
IL (1) IL103005A (OSRAM)
IN (1) IN174169B (OSRAM)
RU (1) RU2123841C1 (OSRAM)
WO (1) WO1993004676A1 (OSRAM)
ZA (1) ZA926709B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101039B (fi) * 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE19901692C2 (de) * 1999-01-18 2002-06-20 Gruenenthal Gmbh Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
DE10003757A1 (de) 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
RU2164796C1 (ru) * 2000-05-25 2001-04-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противогистаминное средство и способ его получения
US20040173147A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US20040173146A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US6962715B2 (en) * 2001-10-24 2005-11-08 Hewlett-Packard Development Company, L.P. Method and dosage form for dispensing a bioactive substance
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
RU2254854C2 (ru) * 2003-09-08 2005-06-27 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Анальгезирующий, жаропонижающий, противовоспалительный препарат и способ его получения
US20050202051A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical vehicle
US20050203482A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical dispensing apparatus and method
JP2008266270A (ja) * 2007-04-25 2008-11-06 Kowa Co イブプロフェン、トラネキサム酸及び糖アルコールを含有する固形製剤
PT3220916T (pt) 2014-11-17 2023-06-26 Eisai R&D Man Co Ltd Método para tratamento de cancro com n-((4,6-dimetil-2-oxo-1,2-di-hidropiridina-3-il)metil)-5-(etil(tetrahidro-2h-piran-4-il) amino)-4-metil-4'-(morfolinometil)-[1,1'-bifenilo]-3-carboxamida

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92752T1 (de) * 1987-07-08 1993-08-15 American Home Prod Spruehgetrocknete ibuprofen-zusammensetzungen.
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US5332834A (en) * 1992-12-02 1994-07-26 Hoechst Celanese Corporation Racemization of an enantomerically enriched α-aryl carboxylic acid

Also Published As

Publication number Publication date
CZ282271B6 (cs) 1997-06-11
US5512302A (en) 1996-04-30
EP0602112B1 (en) 2007-02-07
FI107878B (fi) 2001-10-31
WO1993004676A1 (en) 1993-03-18
ZA926709B (en) 1993-04-28
DE69233678T2 (de) 2008-01-24
FI941046A7 (fi) 1994-03-04
CZ49994A3 (en) 1994-07-13
IN174169B (OSRAM) 1994-10-01
RU2123841C1 (ru) 1998-12-27
AU655673B2 (en) 1995-01-05
FI941046A0 (fi) 1994-03-04
GB9119052D0 (en) 1991-10-23
CA2116956A1 (en) 1993-03-18
DE69233678D1 (de) 2007-03-22
ATE353213T1 (de) 2007-02-15
KR100253046B1 (ko) 2000-05-01
EP0602112A1 (en) 1994-06-22
IL103005A0 (en) 1993-01-31
AU2487092A (en) 1993-04-05
JPH06510532A (ja) 1994-11-24
JP3444597B2 (ja) 2003-09-08
IL103005A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
CA2116956C (en) Pharmaceutical process
Katta et al. Spherical crystallization of benzoic acid
DE69231359T2 (de) Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
CA2644905A1 (en) Ezetimibe compositions
CA2087932A1 (en) Method of producing a solid dispersion of a sparingly water-soluble drug
PT2050445E (pt) Composição farmacêutica de fenofibrato apresentando uma biodisponibilidade elevada e processo para a sua preparação
US20050008691A1 (en) Bicalutamide compositions
JP2023184662A (ja) イストラデフィリン製剤
Rodriguez et al. Preparation and characterization by morphological analysis of diclofenac/PEG 4000 granules obtained using three different techniques
CN102143738A (zh) 药物固体制剂
WO2006045512A1 (en) Solid pharmaceutical composition comprising donepezil hydrochloride
EP2050436A1 (en) Pharmaceutical composition containing dutasteride
WO1997033571A1 (fr) Preparation d'ecadotril a microdispersion et liberation rapides
US20020132010A1 (en) Divalproex sodium dosage forms and a process for their production
JP2004517111A (ja) シタロプラムを含有する薬学的調合物
JP2964195B2 (ja) ピロキシカム錠及びその製造法
JP2022023705A (ja) プラスグレルを含む混合物の混合方法及びその利用
CA2544049A1 (en) Pharmaceutical formulation containing an ltb4 antagonist, method for the production thereof, and use thereof
CA2376155A1 (en) Pharmaceutical composition for oral use
EP1686965A2 (de) Feste pharmazeutische zubereitungsform
EP0535269A1 (en) Pharmaceutical compositions containing thiazolidinedione derivatives
JPH0372424A (ja) 医薬組成物
HK1108280A (en) Ezetimibe compositions
WO2005117840A1 (en) Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20050825